Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Bühring HJ[au]:

A perivascular origin for mesenchymal stem cells in multiple human organs. Crisan M et al. Cell Stem Cell. (2008)

An Fc-optimized CD133 antibody for induction of NK cell reactivity against myeloid leukemia. Koerner SP et al. Leukemia. (2017)

CD molecules 2006--human cell differentiation molecules. Zola H et al. J Immunol Methods. (2007)

Search results

Items: 1 to 50 of 186

1.

An Fc-Optimized CD133 Antibody for Induction of Natural Killer Cell Reactivity against Colorectal Cancer.

Schmied BJ, Riegg F, Zekri L, Grosse-Hovest L, Bühring HJ, Jung G, Salih HR.

Cancers (Basel). 2019 Jun 7;11(6). pii: E789. doi: 10.3390/cancers11060789.

2.

Bone Marrow-Harvesting Technique Influences Functional Heterogeneity of Mesenchymal Stem/Stromal Cells and Cartilage Regeneration.

Sivasubramaniyan K, Ilas DC, Harichandan A, Bos PK, Santos DL, de Zwart P, Koevoet WJLM, Owston H, Bühring HJ, Jones E, van Osch GJVM.

Am J Sports Med. 2018 Dec;46(14):3521-3531. doi: 10.1177/0363546518804807. Epub 2018 Nov 12.

3.

Molecular Signatures of Primary Human Spermatogonial Progenitors and Its Neighboring Peritubular Stromal Compartment.

Harichandan A, Sivasubramaniyan K, Hennenlotter J, Poths S, Bedke J, Kruck S, Stenzl A, Bühring HJ.

Stem Cells Dev. 2017 Feb 15;26(4):263-273. doi: 10.1089/scd.2016.0042. Epub 2016 Dec 16.

PMID:
27821019
4.

An Fc-optimized CD133 antibody for induction of NK cell reactivity against myeloid leukemia.

Koerner SP, André MC, Leibold JS, Kousis PC, Kübler A, Pal M, Haen SP, Bühring HJ, Grosse-Hovest L, Jung G, Salih HR.

Leukemia. 2017 Feb;31(2):459-469. doi: 10.1038/leu.2016.194. Epub 2016 Jul 20.

PMID:
27435001
5.

Expression of the Wnt Receptor Frizzled-4 in the Human Enteric Nervous System of Infants.

Nothelfer K, Obermayr F, Belz N, Reinartz E, Bareiss PM, Bühring HJ, Beschorner R, Just L.

Stem Cells Int. 2016;2016:9076823. doi: 10.1155/2016/9076823. Epub 2015 Nov 30.

6.

Profiling of primary peripheral blood- and monocyte-derived dendritic cells using monoclonal antibodies from the HLDA10 Workshop in Wollongong, Australia.

Autenrieth SE, Grimm S, Rittig SM, Grünebach F, Gouttefangeas C, Bühring HJ.

Clin Transl Immunology. 2015 Nov 13;4(11):e50. doi: 10.1038/cti.2015.29. eCollection 2015 Nov.

7.

Innate immune system favors emergency monopoiesis at the expense of DC-differentiation to control systemic bacterial infection in mice.

Pasquevich KA, Bieber K, Günter M, Grauer M, Pötz O, Schleicher U, Biedermann T, Beer-Hammer S, Bühring HJ, Rammensee HG, Zender L, Autenrieth IB, Lengerke C, Autenrieth SE.

Eur J Immunol. 2015 Oct;45(10):2821-33. doi: 10.1002/eji.201545530. Epub 2015 Jul 24.

8.

Expression of stage-specific embryonic antigen-4 (SSEA-4) defines spontaneous loss of epithelial phenotype in human solid tumor cells.

Sivasubramaniyan K, Harichandan A, Schilbach K, Mack AF, Bedke J, Stenzl A, Kanz L, Niederfellner G, Bühring HJ.

Glycobiology. 2015 Aug;25(8):902-17. doi: 10.1093/glycob/cwv032. Epub 2015 May 15.

9.

Characterization of a bispecific FLT3 X CD3 antibody in an improved, recombinant format for the treatment of leukemia.

Durben M, Schmiedel D, Hofmann M, Vogt F, Nübling T, Pyz E, Bühring HJ, Rammensee HG, Salih HR, Große-Hovest L, Jung G.

Mol Ther. 2015 Apr;23(4):648-55. doi: 10.1038/mt.2015.2. Epub 2015 Jan 12.

10.

Both mature KIR+ and immature KIR- NK cells control pediatric acute B-cell precursor leukemia in NOD.Cg-Prkdcscid IL2rgtmWjl/Sz mice.

Kübler A, Woiterski J, Witte KE, Bühring HJ, Hartwig UF, Ebinger M, Oevermann L, Mezger M, Herr W, Lang P, Handgretinger R, Münz C, André MC.

Blood. 2014 Dec 18;124(26):3914-23. doi: 10.1182/blood-2014-05-572743. Epub 2014 Oct 30.

11.

Update on canine MSC markers.

Tryfonidou MA, Schumann S, Armeanu S, Harichandan A, Sivasubramaniyan K, Mollenhauer J, Bühring HJ.

Cytometry A. 2014 May;85(5):379-81. doi: 10.1002/cyto.a.22469. Epub 2014 Mar 27. No abstract available.

12.

Activated platelets interfere with recruitment of mesenchymal stem cells to apoptotic cardiac cells via high mobility group box 1/Toll-like receptor 4-mediated down-regulation of hepatocyte growth factor receptor MET.

Vogel S, Chatterjee M, Metzger K, Borst O, Geisler T, Seizer P, Müller I, Mack A, Schumann S, Bühring HJ, Lang F, Sorg RV, Langer H, Gawaz M.

J Biol Chem. 2014 Apr 18;289(16):11068-82. doi: 10.1074/jbc.M113.530287. Epub 2014 Feb 24.

13.

Isolation of adult human spermatogonial progenitors using novel markers.

Harichandan A, Sivasubramaniyan K, Hennenlotter J, Schwentner C, Stenzl A, Bühring HJ.

J Mol Cell Biol. 2013 Oct;5(5):351-3. doi: 10.1093/jmcb/mjt029. Epub 2013 Aug 8. No abstract available.

PMID:
23929715
14.

Surface CD24 distinguishes between low differentiated and transit-amplifying cells in the basal layer of human prostate.

Petkova N, Hennenlotter J, Sobiesiak M, Todenhöfer T, Scharpf M, Stenzl A, Bühring HJ, Schwentner C.

Prostate. 2013 Oct;73(14):1576-90. doi: 10.1002/pros.22708. Epub 2013 Jul 8.

PMID:
23836489
15.

Identification of HLA ligands and T-cell epitopes for immunotherapy of lung cancer.

Neumann A, Hörzer H, Hillen N, Klingel K, Schmid-Horch B, Bühring HJ, Rammensee HG, Aebert H, Stevanović S.

Cancer Immunol Immunother. 2013 Sep;62(9):1485-97. doi: 10.1007/s00262-013-1454-2. Epub 2013 Jul 2.

PMID:
23817722
16.

Staphylococcus aureus phenol-soluble modulin peptides modulate dendritic cell functions and increase in vitro priming of regulatory T cells.

Schreiner J, Kretschmer D, Klenk J, Otto M, Bühring HJ, Stevanovic S, Wang JM, Beer-Hammer S, Peschel A, Autenrieth SE.

J Immunol. 2013 Apr 1;190(7):3417-26. doi: 10.4049/jimmunol.1202563. Epub 2013 Mar 4.

17.

Prospective isolation of mesenchymal stem cells from human bone marrow using novel antibodies directed against Sushi domain containing 2.

Sivasubramaniyan K, Harichandan A, Schumann S, Sobiesiak M, Lengerke C, Maurer A, Kalbacher H, Bühring HJ.

Stem Cells Dev. 2013 Jul 1;22(13):1944-54. doi: 10.1089/scd.2012.0584. Epub 2013 Mar 18.

PMID:
23406305
18.

Characterization of peripheral hematopoietic stem cells and monocytes in Parkinson's disease.

Funk N, Wieghofer P, Grimm S, Schaefer R, Bühring HJ, Gasser T, Biskup S.

Mov Disord. 2013 Mar;28(3):392-5. doi: 10.1002/mds.25300. Epub 2013 Feb 7.

PMID:
23401086
19.

Infection-induced bystander-apoptosis of monocytes is TNF-alpha-mediated.

Dreschers S, Gille C, Haas M, Grosse-Ophoff J, Schneider M, Leiber A, Bühring HJ, Orlikowsky TW.

PLoS One. 2013;8(1):e53589. doi: 10.1371/journal.pone.0053589. Epub 2013 Jan 17.

20.

Shared cell surface marker expression in mesenchymal stem cells and adult sarcomas.

Wirths S, Malenke E, Kluba T, Rieger S, Müller MR, Schleicher S, Hann von Weyhern C, Nagl F, Fend F, Vogel W, Mayer F, Kanz L, Bühring HJ, Kopp HG.

Stem Cells Transl Med. 2013 Jan;2(1):53-60. doi: 10.5966/sctm.2012-0055. Epub 2012 Dec 19.

21.

Phenotypic and functional heterogeneity of human bone marrow- and amnion-derived MSC subsets.

Sivasubramaniyan K, Lehnen D, Ghazanfari R, Sobiesiak M, Harichandan A, Mortha E, Petkova N, Grimm S, Cerabona F, de Zwart P, Abele H, Aicher WK, Faul C, Kanz L, Bühring HJ.

Ann N Y Acad Sci. 2012 Aug;1266:94-106. doi: 10.1111/j.1749-6632.2012.06551.x. Review.

PMID:
22901261
22.

Prospective isolation and characterization of human bone marrow-derived MSCs.

Harichandan A, Sivasubramaniyan K, Bühring HJ.

Adv Biochem Eng Biotechnol. 2013;129:1-17. doi: 10.1007/10_2012_147. Review.

PMID:
22825720
23.

Alterations of the RANKL pathway in blood and bone marrow samples of prostate cancer patients without bone metastases.

Todenhöfer T, Hennenlotter J, Schmiedel BJ, Hohneder A, Grimm S, Kühs U, Salih HR, Bühring HJ, Fehm T, Gakis G, Blumenstock G, Aufderklamm S, Schilling D, Stenzl A, Schwentner C.

Prostate. 2013 Jan;73(2):162-8. doi: 10.1002/pros.22551. Epub 2012 Jun 19.

PMID:
22715006
24.

A novel marker of human endometrial mesenchymal stem-like cells.

Masuda H, Anwar SS, Bühring HJ, Rao JR, Gargett CE.

Cell Transplant. 2012;21(10):2201-14. doi: 10.3727/096368911X637362. Epub 2012 Mar 27.

PMID:
22469435
25.

Generation, selection and preclinical characterization of an Fc-optimized FLT3 antibody for the treatment of myeloid leukemia.

Hofmann M, Große-Hovest L, Nübling T, Pyż E, Bamberg ML, Aulwurm S, Bühring HJ, Schwartz K, Haen SP, Schilbach K, Rammensee HG, Salih HR, Jung G.

Leukemia. 2012 Jun;26(6):1228-37. doi: 10.1038/leu.2011.372. Epub 2012 Jan 6.

PMID:
22289926
26.

The "go or grow" potential of gliomas is linked to the neuropeptide processing enzyme carboxypeptidase E and mediated by metabolic stress.

Höring E, Harter PN, Seznec J, Schittenhelm J, Bühring HJ, Bhattacharyya S, von Hattingen E, Zachskorn C, Mittelbronn M, Naumann U.

Acta Neuropathol. 2012 Jul;124(1):83-97. doi: 10.1007/s00401-011-0940-x. Epub 2012 Jan 15.

PMID:
22249620
27.

Human versus porcine mesenchymal stromal cells: phenotype, differentiation potential, immunomodulation and cardiac improvement after transplantation.

Noort WA, Oerlemans MI, Rozemuller H, Feyen D, Jaksani S, Stecher D, Naaijkens B, Martens AC, Bühring HJ, Doevendans PA, Sluijter JP.

J Cell Mol Med. 2012 Aug;16(8):1827-39. doi: 10.1111/j.1582-4934.2011.01455.x.

28.

Prospective isolation of human MSC.

Harichandan A, Bühring HJ.

Best Pract Res Clin Haematol. 2011 Mar;24(1):25-36. doi: 10.1016/j.beha.2011.01.001. Epub 2011 Feb 23. Review.

PMID:
21396590
29.

MSCA-1/TNAP selection of human jaw periosteal cells improves their mineralization capacity.

Alexander D, Schäfer F, Olbrich M, Friedrich B, Bühring HJ, Hoffmann J, Reinert S.

Cell Physiol Biochem. 2010;26(6):1073-80. doi: 10.1159/000323985. Epub 2011 Jan 4.

30.

Regeneration of cartilage and bone by defined subsets of mesenchymal stromal cells--potential and pitfalls.

Aicher WK, Bühring HJ, Hart M, Rolauffs B, Badke A, Klein G.

Adv Drug Deliv Rev. 2011 Apr 30;63(4-5):342-51. doi: 10.1016/j.addr.2010.12.004. Epub 2010 Dec 22. Review.

PMID:
21184789
31.

Immune evasion by Yersinia enterocolitica: differential targeting of dendritic cell subpopulations in vivo.

Autenrieth SE, Linzer TR, Hiller C, Keller B, Warnke P, Köberle M, Bohn E, Biedermann T, Bühring HJ, Hämmerling GJ, Rammensee HG, Autenrieth IB.

PLoS Pathog. 2010 Nov 24;6(11):e1001212. doi: 10.1371/journal.ppat.1001212.

32.

Human term placenta-derived mesenchymal stromal cells are less prone to osteogenic differentiation than bone marrow-derived mesenchymal stromal cells.

Pilz GA, Ulrich C, Ruh M, Abele H, Schäfer R, Kluba T, Bühring HJ, Rolauffs B, Aicher WK.

Stem Cells Dev. 2011 Apr;20(4):635-46. doi: 10.1089/scd.2010.0308. Epub 2011 Jan 27.

PMID:
21047215
33.

Expression profile of the embryonic markers nanog, OCT-4, SSEA-1, SSEA-4, and frizzled-9 receptor in human periodontal ligament mesenchymal stem cells.

Trubiani O, Zalzal SF, Paganelli R, Marchisio M, Giancola R, Pizzicannella J, Bühring HJ, Piattelli M, Caputi S, Nanci A.

J Cell Physiol. 2010 Oct;225(1):123-31. doi: 10.1002/jcp.22203.

PMID:
20458727
34.

Capture of endothelial progenitor cells by a bispecific protein/monoclonal antibody molecule induces reendothelialization of vascular lesions.

Langer HF, von der Ruhr JW, Daub K, Schoenberger T, Stellos K, May AE, Schnell H, Gauss A, Hafner R, Lang P, Schumm M, Bühring HJ, Klingel K, Conrad S, Schaller M, van Zandvoort M, Jung G, Dimmeler S, Skutella T, Gawaz M.

J Mol Med (Berl). 2010 Jul;88(7):687-99. doi: 10.1007/s00109-010-0614-5. Epub 2010 Apr 23.

PMID:
20414631
35.

Prospective isolation of mesenchymal stem cells from multiple mammalian species using cross-reacting anti-human monoclonal antibodies.

Rozemuller H, Prins HJ, Naaijkens B, Staal J, Bühring HJ, Martens AC.

Stem Cells Dev. 2010 Dec;19(12):1911-21. doi: 10.1089/scd.2009.0510. Epub 2010 Aug 12.

PMID:
20367498
36.

The mesenchymal stem cell antigen MSCA-1 is identical to tissue non-specific alkaline phosphatase.

Sobiesiak M, Sivasubramaniyan K, Hermann C, Tan C, Orgel M, Treml S, Cerabona F, de Zwart P, Ochs U, Müller CA, Gargett CE, Kalbacher H, Bühring HJ.

Stem Cells Dev. 2010 May;19(5):669-77. doi: 10.1089/scd.2009.0290.

PMID:
19860546
37.

Phenotypic characterization of distinct human bone marrow-derived MSC subsets.

Bühring HJ, Treml S, Cerabona F, de Zwart P, Kanz L, Sobiesiak M.

Ann N Y Acad Sci. 2009 Sep;1176:124-34. doi: 10.1111/j.1749-6632.2009.04564.x.

PMID:
19796240
38.

LNGFR induction during osteogenesis of human jaw periosteum-derived cells.

Alexander D, Schäfer F, Munz A, Friedrich B, Klein C, Hoffmann J, Bühring HJ, Reinert S.

Cell Physiol Biochem. 2009;24(3-4):283-90. doi: 10.1159/000233253. Epub 2009 Aug 3.

39.

Basic research and clinical applications of non-hematopoietic stem cells, 4-5 April 2008, Tubingen, Germany.

Schäfer R, Dominici M, Müller I, Horwitz E, Asahara T, Bulte JW, Bieback K, Le Blanc K, Bühring HJ, Capogrossi MC, Dazzi F, Gorodetsky R, Henschler R, Handgretinger R, Kajstura J, Kluger PJ, Lange C, Luettichau Iv, Mertsching H, Schrezenmeier H, Sievert KD, Strunk D, Verfaillie C, Northoff H.

Cytotherapy. 2009;11(2):245-55. doi: 10.1080/14653240802582117.

PMID:
19152153
40.

CD203c is overexpressed on neoplastic mast cells in systemic mastocytosis and is upregulated upon IgE receptor cross-linking.

Hauswirth AW, Escribano L, Prados A, Nuñez R, Mirkina I, Kneidinger M, Florian S, Sonneck K, Vales A, Schernthaner GH, Sanchez-Muñoz L, Sperr WR, Bühring HJ, Orfao A, Valent P.

Int J Immunopathol Pharmacol. 2008 Oct-Dec;21(4):797-806.

PMID:
19144265
41.

Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1.

Battula VL, Treml S, Bareiss PM, Gieseke F, Roelofs H, de Zwart P, Müller I, Schewe B, Skutella T, Fibbe WE, Kanz L, Bühring HJ.

Haematologica. 2009 Feb;94(2):173-84. doi: 10.3324/haematol.13740. Epub 2008 Dec 9.

42.

Generation of pluripotent stem cells from adult human testis.

Conrad S, Renninger M, Hennenlotter J, Wiesner T, Just L, Bonin M, Aicher W, Bühring HJ, Mattheus U, Mack A, Wagner HJ, Minger S, Matzkies M, Reppel M, Hescheler J, Sievert KD, Stenzl A, Skutella T.

Nature. 2008 Nov 20;456(7220):344-9. doi: 10.1038/nature07404. Epub 2008 Oct 8. Erratum in: Nature. 2009 Aug 20;460(7258):1044. Retraction in: Nature. 2014 Aug 21;512(7514):338.

PMID:
18849962
43.

A perivascular origin for mesenchymal stem cells in multiple human organs.

Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Park TS, Andriolo G, Sun B, Zheng B, Zhang L, Norotte C, Teng PN, Traas J, Schugar R, Deasy BM, Badylak S, Buhring HJ, Giacobino JP, Lazzari L, Huard J, Péault B.

Cell Stem Cell. 2008 Sep 11;3(3):301-13. doi: 10.1016/j.stem.2008.07.003.

44.

A stable niche supports long-term maintenance of human epidermal stem cells in organotypic cultures.

Muffler S, Stark HJ, Amoros M, Falkowska-Hansen B, Boehnke K, Bühring HJ, Marmé A, Bickenbach JR, Boukamp P.

Stem Cells. 2008 Oct;26(10):2506-15. doi: 10.1634/stemcells.2007-0991. Epub 2008 Jul 24.

45.

Recombinant allergens promote expression of aminopeptidase-n (CD13) on basophils in allergic patients.

Sonneck K, Baumgartner C, Rebuzzi L, Marth K, Chen KW, Hauswirth AW, Florian S, Vrtala S, Bühring HJ, Valenta R, Valent P.

Int J Immunopathol Pharmacol. 2008 Jan-Mar;21(1):11-21.

PMID:
18336727
46.

Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells.

Parolini O, Alviano F, Bagnara GP, Bilic G, Bühring HJ, Evangelista M, Hennerbichler S, Liu B, Magatti M, Mao N, Miki T, Marongiu F, Nakajima H, Nikaido T, Portmann-Lanz CB, Sankar V, Soncini M, Stadler G, Surbek D, Takahashi TA, Redl H, Sakuragawa N, Wolbank S, Zeisberger S, Zisch A, Strom SC.

Stem Cells. 2008 Feb;26(2):300-11. Epub 2007 Nov 1. Review.

47.

Prospective isolation and characterization of mesenchymal stem cells from human placenta using a frizzled-9-specific monoclonal antibody.

Battula VL, Treml S, Abele H, Bühring HJ.

Differentiation. 2008 Apr;76(4):326-36. Epub 2007 Oct 9.

PMID:
17924962
48.

Chondrogenic potential of human adult mesenchymal stem cells is independent of age or osteoarthritis etiology.

Scharstuhl A, Schewe B, Benz K, Gaissmaier C, Bühring HJ, Stoop R.

Stem Cells. 2007 Dec;25(12):3244-51. Epub 2007 Sep 13.

49.

Selective induction of apoptosis in leukemic B-lymphoid cells by a CD19-specific TRAIL fusion protein.

Stieglmaier J, Bremer E, Kellner C, Liebig TM, ten Cate B, Peipp M, Schulze-Koops H, Pfeiffer M, Bühring HJ, Greil J, Oduncu F, Emmerich B, Fey GH, Helfrich W.

Cancer Immunol Immunother. 2008 Feb;57(2):233-46. Epub 2007 Jul 31.

PMID:
17665197
50.

Potent costimulation of human CD8 T cells by anti-4-1BB and anti-CD28 on synthetic artificial antigen presenting cells.

Rudolf D, Silberzahn T, Walter S, Maurer D, Engelhard J, Wernet D, Bühring HJ, Jung G, Kwon BS, Rammensee HG, Stevanović S.

Cancer Immunol Immunother. 2008 Feb;57(2):175-83. Epub 2007 Jul 27.

PMID:
17657490

Supplemental Content

Loading ...
Support Center